Company intelligence
botiss biomaterials
The future in regeneration is now.
About botiss biomaterials
botiss biomaterials is one of the leading companies in the field of dental bone and tissue regeneration. The botiss regeneration system is available in over 100 countries worldwide via a global network of distribution partners and employees, who are committed experts in the field of oral surgery and implantology. The products of the botiss regeneration system have proven their success in terms of safety, efficacy, and reliability in a multitude of preclinical and clinical studies and, most importantly, in the daily clinical work, with hundreds of thousands of patients worldwide. We substantially invest in RESEARCH and EDUCATION. Unique innovations, such as mucoderm®, maxgraft® bonebuilder, and cerabone® plus, the concept of high-quality learning and education with the botiss academy, and our international bone & tissue days are the results of our partnership with worldwide renowned academic research institutes, global opinion leaders, and practitioners in their daily clinical environment.
Verified activity
Signals from botiss biomaterials
8 published signals
Presence & Recognition
botiss biomaterials welcomed clinicians from different countries to the headquarters for a day of clinical exchange, regenerative concepts, and international networking.
Reported by botiss biomaterials
Presence & Recognition
botiss biomaterials is hosting a full day event on bone and soft tissue management of advanced implant cases at Doha on 8 October 2026 featuring lectures on immediate placement vs. socket grafting and managing atrophic ridges with magnesium plates.
Reported by botiss biomaterials
Presence & Recognition
botiss biomaterials is attending the 33rd EAO Annual Congress in Lisbon, Portugal from 24 to 26 September 2026.
Reported by botiss biomaterials
Research & Knowledge
botiss biomaterials published an expert talk discussing soft tissue thickness and soft tissue augmentation in immediate implant placement.
Reported by botiss biomaterials
Presence & Recognition
botiss biomaterials presented a hands-on workshop exploring the Novamag Shield, a durable and non-toxic agnostic material for socket management on September 19, 2026 at the Palermo location.
Reported by botiss biomaterials
Research & Knowledge
botiss biomaterials published a clinical study titled Mounssif et al. (2026). J. Funct. Biomater. 2026, 17(7), 328, detailing a post-extractive alveolar ridge reconstruction case involving SHIELD, cerabone, and mucoderm.
Reported by botiss biomaterials
Presence & Recognition
botiss biomaterials hosted a bone and soft tissue regeneration event at the Handelsbeurs Antwerpen on September 19, 2026, featuring speakers including Dr. László Párkányi, Prof. Dr. Adrian Kasaj, Dr. Victoria Ivancheva, Dr. Irfan Abas, and Prof. Dr. Cristian Dinu.
Reported by botiss biomaterials
Presence & Recognition
botiss biomaterials attended a two-day program at the Branemark Center in Perth featuring presentations and clinical simulation practicals on soft tissue augmentation presented by Dr Giorgio Tabanella.
Reported by botiss biomaterials